Krishnan Krish S 4
4 · Krystal Biotech, Inc. · Filed Mar 6, 2026
Research Summary
AI-generated summary of this filing
Krystal (KRYS) 10% Owner Krishnan Krish Sells Shares
What Happened Krishnan Krish, a 10% owner of Krystal Biotech (KRYS), sold 25,000 shares on March 4, 2026 in multiple open-market trades (reported March 6, 2026). Total proceeds were approximately $6,579,164. Individual blocks included: 483 sh @ $257.31 ($124,282); 470 @ $258.38 ($121,438); 1,377 @ $259.87 ($357,838); 3,128 @ $260.49 ($814,802); 2,962 @ $261.41 ($774,289); 2,380 @ $262.44 ($624,619); 2,043 @ $263.70 ($538,741); 8,798 @ $264.85 ($2,330,151); 2,439 @ $265.59 ($647,773); and 920 @ $266.56 ($245,231). Overall prices were roughly in the $257–$266.6 range. These were sales (S), which are generally routine dispositions rather than a purchase/bullish signal.
Key Details
- Transaction date: March 4, 2026; Form 4 filed March 6, 2026 (appears timely — filed within typical two business days).
- Total sold: 25,000 shares for ~ $6.58 million.
- Price details: reported as weighted averages for multiple-trade batches; reported per-block prices and underlying ranges are documented in footnotes (approx ranges from ~$256.81 up to ~$266.93 across trades).
- Plan: Sales were made pursuant to a Rule 10b5-1 trading plan adopted Sept 4, 2025 (effective Dec 4, 2025 through Dec 4, 2026) — indicates pre-planned trades.
- Ownership reporting: Krish may be deemed to beneficially own shares held by his spouse and the Krishnan Family Trust; those holdings/transactions are reported separately by his spouse/trust on other Form 4s. This filing does not disclose "shares owned after the transaction."
- Transaction code: S = Sale.
Context
- Rule 10b5-1 plans allow insiders to sell shares at pre-set times to avoid trading on nonpublic information; disclosures note these trades followed such a plan.
- As a 10% owner, Krish is a significant insider; sales by large holders can be for many reasons (portfolio management, diversification, tax planning) — the filing itself gives no motive.
- No derivatives, option exercises, gifts, or tax-withholding transactions are reported in this filing.
Insider Transaction Report
Form 4
Krishnan Krish S
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-03-04$257.31/sh−483$124,282→ 1,499,770 total - Sale
Common Stock
[F4]2026-03-04$258.38/sh−470$121,438→ 1,499,300 total - Sale
Common Stock
[F5]2026-03-04$259.87/sh−1,377$357,838→ 1,497,923 total - Sale
Common Stock
[F6]2026-03-04$260.49/sh−3,128$814,802→ 1,494,795 total - Sale
Common Stock
[F7]2026-03-04$261.41/sh−2,962$774,289→ 1,491,833 total - Sale
Common Stock
[F8]2026-03-04$262.44/sh−2,380$624,619→ 1,489,453 total - Sale
Common Stock
[F9]2026-03-04$263.70/sh−2,043$538,741→ 1,487,410 total - Sale
Common Stock
[F10]2026-03-04$264.85/sh−8,798$2,330,151→ 1,478,612 total - Sale
Common Stock
[F11]2026-03-04$265.59/sh−2,439$647,773→ 1,476,173 total - Sale
Common Stock
[F12]2026-03-04$266.56/sh−920$245,231→ 1,475,253 total
Holdings
- 90,000(indirect: By Trust)
Common Stock
- 50,000(indirect: By Trust)
Common Stock
[F13]
Footnotes (13)
- [F1]The Reporting Person may be deemed to beneficially own shares of the Issuer's common stock directly owned by the Reporting Person's spouse, Suma M. Krishnan. Such shares and transactions by the Reporting Person's spouse are not included in this Form 4, as they are being reported separately on a Form 4 filed by his spouse. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
- [F10]The transaction was executed in multiple trades ranging from $264.2 to $265.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F11]The transaction was executed in multiple trades ranging from $265.235 to $266.19. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F12]The transaction was executed in multiple trades ranging from $266.36 to $266.93. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F13]Directly beneficially owned by the Krishnan Family Trust. The Reporting Person and his spouse are each joint beneficial owners of the trust with joint voting and investment control, and holdings and transactions by the Krishnan Family Trust are also reflected on the separate Form 4 filed by his spouse.
- [F2]The sales reported were pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2025. The Rule 10b5-1 trading plan started on December 4, 2025 and will terminate on December 4, 2026, or earlier in accordance with the terms of the Rule 10b5-1 trading plan, including upon completion of the sale of all of the shares of the Company's common stock subject to the Rule 10b5-1 trading plan.
- [F3]The transaction was executed in multiple trades ranging from $256.81 to $257.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F4]The transaction was executed in multiple trades ranging from $257.89 to $258.765. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F5]The transaction was executed in multiple trades ranging from $259.07 to $260.06. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F6]The transaction was executed in multiple trades ranging from $260.07 to $261.06. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F7]The transaction was executed in multiple trades ranging from $261.07 to $262.04. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F8]The transaction was executed in multiple trades ranging from $262.08 to $263. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
- [F9]The transaction was executed in multiple trades ranging from $263.19 to $264.1. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.
Signature
/s/ Krish S. Krishnan|2026-03-06